16-28 of 28
Evaluating Heterogeneous Treatment Effects in Pursuit of Personalized Multiple Sclerosis Care
Practical Neurology: Focus on Multiple SclerosisEvaluating Heterogeneous Treatment Effects in Pursuit of Personalized Multiple Sclerosis Care
Albert Aboseif, DO
Daniel Orme, MD
Tanuja Chitnis, MD
Carrie M. Hersh, DO, MSc, FAAN
MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Practical Neurology: Focus on Multiple SclerosisMS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Cristina Valencia-Sanchez, MD, PhD
Dean Wingerchuk, MD
MS Minute: Cognitive Dysfunction in People Living with Multiple Sclerosis
Practical Neurology: Focus on Multiple SclerosisMS Minute: Cognitive Dysfunction in People Living with Multiple Sclerosis
Sophia Marchetti, BASc
Anthony Feinstein, MD
MS Minute: Menopause and Multiple Sclerosis
Practical Neurology: Focus on Multiple SclerosisMS Minute: Menopause and Multiple Sclerosis
Denisse Morales-Rodriguez, BS
Riley Bove, MD, MMSc
The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
Practical Neurology: Focus on Multiple SclerosisThe Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
Justine Itorralba, MB, BCh, BAO, MSc
Raphael Schneider, MD, PhD, FRCPC, CIP
Management Approaches in Radiographically Isolated Syndrome
Practical Neurology: Focus on Multiple SclerosisManagement Approaches in Radiographically Isolated Syndrome
Annalisa Morgan, MD
Erin Longbrake, MD, PhD
- advertisement
Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
Practical Neurology: Focus on Multiple SclerosisIdentification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
Lauren Beranek, BS
Kaylan Fenton, APNP
Ahmed Z. Obeidat, MD, PhD
Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
Practical Neurology: Focus on Multiple SclerosisFatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
Elise Johnson, MD
Sara J. Hooshmand, MD
Sam I. Hooshmand, DO
Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
Practical Neurology: Focus on Multiple SclerosisSafety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
Aisha Elfasi, MD
Jonathan D. Krett, MD
Brendan Lindgren, DO
Scott D. Newsome, DO
Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
Practical Neurology: Focus on Multiple SclerosisRelapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
Chelsie A. Thompson, DO
Lakshman Arcot Jayagopal, MD
Rana K. Zabad, MD, FAAN
Opportunities and Challenges in the Treatment of Pediatric-Onset Multiple Sclerosis with Highly Active Disease-Modifying Therapies
Practical Neurology: Focus on Multiple SclerosisOpportunities and Challenges in the Treatment of Pediatric-Onset Multiple Sclerosis with Highly Active Disease-Modifying Therapies
Sophie Zacharek, BS
Jennifer Yang, MD
Jennifer S. Graves, MD, PhD, MAS
MS Minute: Mood Disorders and Multiple Sclerosis
Practical Neurology: Focus on Multiple SclerosisMS Minute: Mood Disorders and Multiple Sclerosis
Rosalind Kalb, PhD
- advertisement
MS Minute: Disparities in Multiple Sclerosis: Incorporating Equity Into Clinical Care and Research
Practical Neurology: Focus on Multiple SclerosisMS Minute: Disparities in Multiple Sclerosis: Incorporating Equity Into Clinical Care and Research
Barbara S. Giesser, MD, FAAN, FANA
Gopika Govindan Kutty, MD
Tirisham V. Gyang, MD
Lawrence Samkoff, MD, FAAN
